Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours

In conclusion, reovirus is well‐tolerated and can be given safely to tumour‐bearing dogs according to the dosing regimen used in this study without significant concerns of viral shedding. Reovirus is also potentially effective in various types of canine tumours.

Source: Veterinary and Comparative Oncology - September 1, 2017 Category: Veterinary Research Authors: C. C. Hwang, M. Igase, M. Sakurai, T. Haraguchi, K. Tani, K. Itamoto, T. Shimokawa, M. Nakaichi, Y. Nemoto, S. Noguchi, M. Coffey, M. Okuda, T. Mizuno Tags: ORIGINAL ARTICLE Source Type: research